Thursday, September 27, 2012

Importance of Development Strategies for Life Cycle Management of Safe and Effective Medical Products - 9th DIA Japan Annual Meeting


 
 
9th DIA Japan Annual Meeting | Importance of Development Strategies for Life Cycle Management of Safe and Effective Medical Products | November
19-21, 2012 | Tokyo, Japan
News & PublicationsMeetings & TrainingsSpeaking & PublishingNetworking
& CommunitiesExhibiting AdvertisingCareer Center
9th DIA Japan Annual Meeting Program
Now Available!
Prepare for Japan’s Annual Meeting by choosing what events and sessions you would like to attend. Informative tutorials, outstanding speakers, excellent presenters, interactive sessions and exciting network opportunities await you!
 
3 days of interacting with biopharmaceutical industry, contract service organizations, regulatory agencies, health ministries, patient organizations, universities and students from throughout Japan and worldwide. Plus, attend the DIA Awards Presentation, with presenter and DIA Board President Ling Su, PhD.
 
Program now available here!
       
Register today for the early bird special until October 29!
UPCOMING EVENTS
Clinical Forum | The Hague 2012 | The Empowered Patient | 8-10 October 2012 | The Hague, The Netherlands
Tutorials and Keynote Speeches
Tutorials:
Tutorial 1: Company Core Data Sheets Prepared by Western Companies
Tutorial 2: Roundtable Discussion: What are Preferable Skill Sets in Clinical Development
Tutorial 3: Group Work: Action Learning for Six Sig
Tutorial 4: Risk Management Plan - Standard (As of 10/30/2012)
Tutorial 5: Leadership and Philosophy: Best Practice
Tutorial 6: Basic Understanding of Bioequivalence
 
Don’t Miss the Keynote Speeches!
Keynote Speaker 1: Peter Bachmann, DrSc
European and International Affairs Member of the CMDh
(Co-ordination Group for Mutual Recognition and
Decentralised Procedures - Human) on the Latest Regulatory Environment in EU - from Development to Post-Marketing.

Keynote Speech 2: Takao Yamori, PhD
Director of Center for Product Evaluation, Pharmaceuticals and Medical Devices Agency (PMDA) to discuss the New Drug Development of Japan Origin through Industry-Academia Collaboration.
 FacebookLinkedInTwitterYouTube
 

一般社団法人ディー・アイ・エー・ジャパン
106-0041 東京都港区麻布台1-11-10
Tel. +03-5575-2130
Fax. +03-3583-1200
email: diajapan@diajapan.org

No comments:

Post a Comment